Join Ben Jackson, EVP North American Sales, in Boston from April 23-25 at the upcoming World Orphan Drug Congress – an event focused on advancing orphan drug development and enhancing access to life-saving therapies.
At BC Platforms, our commitment to rare diseases is driven by an understanding of the challenges and needs within this field. Through innovative use of Real-World Data (RWD), we deliver actionable intelligence from data that enhances clinical evidence and facilitates more precise treatments. The focus is on reducing patient burden while providing clearer insights into disease pathways and treatment outcomes.
Discover more about our work by downloading our latest factsheet: Rare Disease and Integrated Real-World Data Factsheet
We are proud to attend and speak at the 2nd edition of Industry Symposium on “AI in the Life Sciences”! This event brings together experts to explore translational AI research that is clearly relevant to application in the Life Sciences industries, namely the pharmaceutical industry, but also the biotech and medtech industries. Come heart our CSO
We are proud to partner in the upcoming 13th IMPACCT Real World Evidence US Summit! The Summit brings together industry leaders in RWE and Evidence Generation to explore the latest innovations in utilizing real-world data across the drug development lifecycle. The summit offers a unique opportunity to discuss key strategies for enhancing RWE with AI,
BC Platforms is excited to attend the 2025 EUCAIM events to join forces in advancing AI-powered imaging to save lives. The event agenda includes the EUCAIM Consortium Meeting, European Cancer Imaging Initiative event, and EUCAIM Workshops. Read more about the event here.
